eTable 2. Associations between changes in patient activation (PAM13-D) and patient characteristics, changes in health behaviors and clinical parameters.

Patient characteristics T1 vs. T0	PAM13-D T1 vs. T0
	Correlation coefficient*1	n
Risk factors (RF) T1 vs. T0*2
RF total mean value T1 vs. T0	−0.329	77
Smoking T1 vs. T0	0.079	76
Overweight T1 vs. T0	0.056	74
Poor diet T1 vs. T0	−0,418	77
Lack of exercise T1 vs. T0	−0.254	75
Stress and hecticness T1 vs. T0	−0.198	76
Alcohol consumption T1 vs. T0	−0.102	77
Changes in health behaviors T1*3	0.171	70
EQ-VAS T1 vs. T0*4	0.087	72
Body mass index T1 vs. T0	−0.110	71
Clinical parameters T1 vs. T0
Systolic blood pressure T1 vs. T0	−0.086	76
Total cholesterol T1 vs. T0	−0.298	76
HDL cholesterol T1 vs. T0	−0.075	76
CVR score T1 vs. T0*5	−0.090	76

CVR score, cardiovascular risk score, EQ-VAS, European quality of life—visual analogue scale (subjective health); HDL cholesterol, high density lipoprotein cholesterol;

n, number; PAM13-D, German version of Patient Activation Measure questionnaire with scores from 0 (lowest level of patient activation) to 100 (highest level of patient activation);

T0, time point of study inclusion (baseline); T1, time point after four months (follow-up)

*¹ Correlation coefficient Spearman‘s rho

*² Risk factors with scores from 0 (not at all) to 4 (strong)

*³ Change in health behaviors: score of 1 (less healthy), 2 (unchanged), 3 (healthier)

*⁴ EQ-VAS scores from 0 (worst health) to 100 (best health)

*⁵ CVR scores from 0 % (lowest risk) to 51 % (highest calculated risk; manifest ?arteriosclerosis)